Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Pharmaceuticals - NEC
- Sub-Industry: Life Sciences Tools & Services
- Symbol: NYSE:CBM
- CUSIP: 13201110
- Web: www.cambrex.com
Capitalization:- Market Cap: $1.92 billion
- Outstanding Shares: 32,566,000
Average Prices:- 50 Day Moving Avg: $58.42
- 200 Day Moving Avg: $55.19
- 52 Week Range: $38.30 - $62.95
P/E:- Trailing P/E Ratio: 22.50
- Foreward P/E Ratio: 18.21
- P/E Growth: 1.30
Sales & Book Value:- Annual Revenue: $500.61 million
- Price / Sales: 3.84
- Book Value: $13.22 per share
- Price / Book: 4.46
Profitability:- EBIDTA: $161.83 million
- Net Margins: 17.36%
- Return on Equity: 24.92%
- Return on Assets: 16.63%
Debt:- Current Ratio: 3.92%
- Quick Ratio: 2.13%
Misc:- Average Volume: 256,165 shs.
- Beta: 2.28
- Short Ratio: 9.07
Frequently Asked Questions for Cambrex Corporation (NYSE:CBM)
What is Cambrex Corporation's stock symbol?
Cambrex Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBM."
How were Cambrex Corporation's earnings last quarter?
Cambrex Corporation (NYSE:CBM) issued its quarterly earnings data on Thursday, May, 4th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.51 by $0.17. The company earned $105.01 million during the quarter, compared to the consensus estimate of $99.05 million. Cambrex Corporation had a net margin of 17.36% and a return on equity of 24.92%. Cambrex Corporation's revenue for the quarter was up 10.9% on a year-over-year basis. During the same quarter last year, the company earned $0.50 earnings per share. View Cambrex Corporation's Earnings History.
When will Cambrex Corporation make its next earnings announcement?
What guidance has Cambrex Corporation issued on next quarter's earnings?
Cambrex Corporation issued an update on its FY17 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $2.94-3.06 for the period, compared to the Thomson Reuters consensus estimate of $3.01. The company issued revenue guidance of +7-11% to ~$524.62-544.233 million, compared to the consensus revenue estimate of $535.27 million.
Where is Cambrex Corporation's stock going? Where will Cambrex Corporation's stock price be in 2017?
3 brokers have issued 12 month price targets for Cambrex Corporation's stock. Their forecasts range from $61.00 to $70.00. On average, they expect Cambrex Corporation's stock price to reach $65.67 in the next year. View Analyst Ratings for Cambrex Corporation.
Who are some of Cambrex Corporation's key competitors?
Some companies that are related to Cambrex Corporation include Opko Health (OPK), Hikma Pharmaceuticals Plc (HIK), BTG plc (BTG), Horizon Pharma PLC (HZNP), Amicus Therapeutics (FOLD), Theravance Biopharma (TBPH), Pacira Pharmaceuticals (PCRX), Innoviva (INVA), Impax Laboratories (IPXL), Corcept Therapeutics Incorporated (CORT), Amphastar Pharmaceuticals (AMPH), Lannett Co (LCI), AMAG Pharmaceuticals (AMAG), SciClone Pharmaceuticals (SCLN), Aceto Corporation (ACET), Teligent (TLGT), Collegium Pharmaceutical (COLL) and Aquinox Pharmaceuticals (AQXP).
Who are Cambrex Corporation's key executives?
Cambrex Corporation's management team includes the folowing people:
- Steven Mark Klosk, President, Chief Executive Officer, Director
- Tom George Vadaketh, Chief Financial Officer, Executive Vice President
- Shawn P. Cavanagh, Chief Operating Officer, Executive Vice President
- Gregory P. Sargen, Executive Vice President, Corporate Development and Strategy
- Samantha M. Hanley, Vice President, General Counsel,Corporate Secretary
- James G. Farrell, Vice President and Corporate Controller
- Shlomo Yanai, Non-Executive Chairman of the Board
- Rosina B. Dixon M.D., Independent Director
- Claes Glassell, Independent Director
- Louis J. Grabowsky, Independent Director
Who owns Cambrex Corporation stock?
Cambrex Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Congress Asset Management Co. MA (3.98%), Public Employees Retirement Association of Colorado (1.07%), Tributary Capital Management LLC (0.58%), Acadian Asset Management LLC (0.55%), Eqis Capital Management Inc. (0.24%) and First Quadrant L P CA (0.22%). Company insiders that own Cambrex Corporation stock include Gregory Sargen, Ilan Kaufthal, Leon J Hendrix Jr, Leon J Hendrix, Jr, Louis J Grabowsky, Peter G Tombros, Samantha Hanley, Shawn Cavanagh, Steven M Klosk and William B Korb. View Institutional Ownership Trends for Cambrex Corporation.
Who sold Cambrex Corporation stock? Who is selling Cambrex Corporation stock?
Cambrex Corporation's stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Russell Investments Group Ltd., Bank of Montreal Can, First Quadrant L P CA, Independent Portfolio Consultants Inc., First Citizens Bank & Trust Co., Boston Advisors LLC and Capstone Asset Management Co.. Company insiders that have sold Cambrex Corporation stock in the last year include Gregory Sargen, Leon J Hendrix Jr, Samantha Hanley, Shawn Cavanagh and Steven M Klosk. View Insider Buying and Selling for Cambrex Corporation.
Who bought Cambrex Corporation stock? Who is buying Cambrex Corporation stock?
Cambrex Corporation's stock was bought by a variety of institutional investors in the last quarter, including Congress Asset Management Co. MA, Legato Capital Management LLC, Public Employees Retirement Association of Colorado, Tributary Capital Management LLC, Eqis Capital Management Inc., Thomson Horstmann & Bryant Inc., Atria Investments LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Cambrex Corporation.
How do I buy Cambrex Corporation stock?
Shares of Cambrex Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cambrex Corporation's stock price today?
One share of Cambrex Corporation stock can currently be purchased for approximately $59.00.
MarketBeat Community Rating for Cambrex Corporation (NYSE CBM)MarketBeat's community ratings are surveys of what our community members think about Cambrex Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Cambrex Corporation (NYSE:CBM)Earnings History by Quarter for Cambrex Corporation (NYSE CBM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/31/2017 | | $0.76 | | | | | N/A |  |
| 5/4/2017 | Q1 2017 | $0.51 | $0.68 | $99.05 million | $105.01 million | View | Listen | |
| 2/3/2017 | Q416 | $1.05 | $1.23 | $174.53 million | $178.70 million | View | Listen | |
| 11/4/2016 | Q3 | $0.41 | $0.47 | $96.07 million | $99.90 million | View | Listen | |
| 7/28/2016 | Q216 | $0.59 | $0.68 | $114.85 million | $118.22 million | View | Listen | |
| 4/29/2016 | Q116 | $0.34 | $0.50 | $83.61 million | $94.74 million | View | Listen | |
| 2/9/2016 | Q4 | $0.83 | $0.53 | $152.94 million | $156.90 million | View | Listen | |
| 11/3/2015 | Q3 | $0.38 | $0.40 | $101.09 million | $92.97 million | View | Listen | |
| 7/30/2015 | Q215 | $0.44 | $0.63 | $110.03 million | $106.40 million | View | Listen | |
| 5/1/2015 | Q115 | $0.23 | $0.29 | $76.01 million | $78.20 million | View | Listen | |
| 2/6/2015 | Q414 | $0.50 | $0.60 | $117.90 million | $128.80 million | View | Listen | |
| 10/30/2014 | Q314 | $0.29 | $0.28 | $94.25 million | $81.10 million | View | Listen | |
| 8/12/2014 | | $0.21 | $0.32 | | | View | N/A | |
| 8/1/2014 | Q214 | $0.28 | $0.32 | $92.70 million | $98.00 million | View | Listen | |
| 5/2/2014 | Q114 | $0.23 | $0.05 | $79.40 million | $66.20 million | View | Listen | |
| 2/11/2014 | Q4 | $0.30 | $0.30 | $95.25 million | $103.00 million | View | Listen | |
| 11/1/2013 | Q313 | $0.21 | $0.20 | $83.60 million | $78.00 million | View | Listen | |
| 8/1/2013 | Q2 2013 | $0.26 | $0.10 | $73.70 million | $61.60 million | View | Listen | |
| 5/3/2013 | Q1 2013 | $0.22 | $0.36 | $76.15 million | $74.58 million | View | Listen | |
| 2/6/2013 | Q4 2012 | $0.13 | $0.26 | $68.30 million | $69.93 million | View | Listen | |
| 11/5/2012 | Q312 | $0.12 | $0.07 | $61.00 million | $59.21 million | View | N/A | |
| 8/1/2012 | | $0.21 | $0.33 | | | View | N/A | |
| 5/3/2012 | | $0.14 | $0.24 | | | View | N/A | |
| 2/6/2012 | | $0.12 | $0.10 | | | View | N/A | |
| 11/3/2011 | | $0.07 | $0.10 | | | View | N/A | |
| 8/2/2011 | | $0.13 | $0.16 | | | View | N/A | |
| 5/5/2011 | | $0.08 | $0.10 | | | View | N/A | |
| 2/10/2011 | | $0.10 | $0.16 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Cambrex Corporation (NYSE:CBM)2017 EPS Consensus Estimate: $2.90
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.48 | $0.51 | $0.50 |
| Q2 2017 | 2 | $0.71 | $0.74 | $0.73 |
| Q3 2017 | 2 | $0.46 | $0.52 | $0.49 |
| Q4 2017 | 2 | $1.17 | $1.20 | $1.19 |
| Q1 2018 | 1 | $0.58 | $0.58 | $0.58 |
(Data provided by Zacks Investment Research)
Dividend History for Cambrex Corporation (NYSE:CBM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Cambrex Corporation (NYSE:CBM)Insider Ownership Percentage: 2.48%
Institutional Ownership Percentage: 98.28%
Insider Trades by Quarter for Cambrex Corporation (NYSE:CBM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/3/2017 | Steven M Klosk | CEO | Sell | 12,000 | $59.66 | $715,920.00 | |
| 6/12/2017 | Samantha Hanley | VP | Sell | 14,000 | $57.56 | $805,840.00 | |
| 6/6/2017 | Leon J Hendrix Jr | Director | Sell | 20,656 | $55.95 | $1,155,703.20 | |
| 6/1/2017 | Steven M Klosk | CEO | Sell | 12,000 | $54.19 | $650,280.00 | |
| 5/1/2017 | Steven M Klosk | CEO | Sell | 12,000 | $58.20 | $698,400.00 | |
| 4/3/2017 | Steven M Klosk | CEO | Sell | 12,000 | $54.58 | $654,960.00 | |
| 3/1/2017 | Steven M Klosk | CEO | Sell | 12,000 | $56.70 | $680,400.00 | |
| 2/27/2017 | Shawn Cavanagh | COO | Sell | 19,620 | $55.95 | $1,097,739.00 | |
| 2/16/2017 | Steven M Klosk | CEO | Sell | 23,822 | $52.50 | $1,250,655.00 | |
| 2/13/2017 | Steven M Klosk | CEO | Sell | 63,178 | $52.55 | $3,320,003.90 | |
| 2/7/2017 | Gregory Sargen | EVP | Sell | 30,000 | $54.88 | $1,646,400.00 | |
| 2/7/2017 | Shawn Cavanagh | COO | Sell | 20,380 | $55.12 | $1,123,345.60 | |
| 12/14/2016 | Shawn Cavanagh | COO | Sell | 30,000 | $53.58 | $1,607,400.00 | |
| 11/11/2016 | Gregory Sargen | Insider | Sell | 22,500 | $52.02 | $1,170,450.00 | |
| 7/11/2016 | William B Korb | Director | Sell | 3,420 | $55.00 | $188,100.00 | |
| 6/8/2016 | William B Korb | Director | Sell | 4,142 | $52.47 | $217,330.74 | |
| 6/1/2016 | William B Korb | Director | Sell | 8,000 | $51.06 | $408,480.00 | |
| 5/9/2016 | Steven M Klosk | CEO | Sell | 14,005 | $49.00 | $686,245.00 | |
| 5/5/2016 | Steven M Klosk | CEO | Sell | 16,430 | $49.13 | $807,205.90 | |
| 5/3/2016 | William B Korb | Director | Sell | 8,000 | $49.09 | $392,720.00 | |
| 3/16/2016 | Steven M Klosk | CEO | Sell | 19,565 | $41.00 | $802,165.00 | |
| 3/15/2016 | Louis J Grabowsky | Director | Buy | 750 | $40.10 | $30,075.00 | |
| 3/10/2016 | William B Korb | Director | Sell | 8,000 | $41.38 | $331,040.00 | |
| 2/11/2016 | Gregory Sargen | CFO | Sell | 13,622 | $36.16 | $492,571.52 | |
| 2/11/2016 | Shawn Cavanagh | COO | Sell | 18,342 | $36.13 | $662,696.46 | |
| 2/11/2016 | Steven M. Klosk | CEO | Sell | 39,542 | $36.20 | $1,431,420.40 | |
| 12/15/2015 | Leon J. Hendrix, Jr. | Director | Sell | 7,000 | $51.34 | $359,380.00 | |
| 12/11/2015 | Peter G. Tombros | Director | Sell | 31,236 | $51.37 | $1,604,593.32 | |
| 11/30/2015 | Ilan Kaufthal | Director | Sell | 52,315 | $54.32 | $2,841,750.80 | |
| 11/13/2015 | Gregory Sargen | CFO | Sell | 28,750 | $49.14 | $1,412,775.00 | |
| 11/6/2015 | Samantha Hanley | VP | Sell | 15,000 | $52.03 | $780,450.00 | |
| 8/27/2015 | William B. Korb | Director | Sell | 3,600 | $48.00 | $172,800.00 | |
| 5/21/2015 | Ilan Kaufthal | Director | Sell | 50,000 | $41.31 | $2,065,500.00 | |
| 5/11/2015 | Gregory Sargen | CFO | Sell | 25,000 | $38.44 | $961,000.00 | |
| 2/12/2015 | Aldo Magnini | Director | Sell | 7,500 | $32.75 | $245,625.00 | |
| 2/12/2015 | Gregory Sargen | CFO | Sell | 25,000 | $32.64 | $816,000.00 | |
| 2/10/2015 | Steven M Klosk | CEO | Sell | 45,000 | $30.32 | $1,364,400.00 | |
| 9/11/2014 | Shawn Cavanagh | COO | Sell | 56,251 | $22.56 | $1,269,022.56 | |
| 9/3/2014 | Steven M Klosk | CEO | Sell | 126,257 | $22.01 | $2,778,916.57 | |
| 9/2/2014 | William M Haskel | SVP | Sell | 9,400 | $21.94 | $206,236.00 | |
| 8/19/2014 | Steven M Klosk | CEO | Sell | 4,702 | $22.00 | $103,444.00 | |
| 8/7/2014 | Steven M Klosk | CEO | Sell | 1,200 | $22.52 | $27,024.00 | |
| 8/7/2014 | William M Haskel | SVP | Sell | 28,100 | $22.50 | $632,250.00 | |
| 8/5/2014 | Gregory Sargen | CFO | Sell | 50,000 | $22.34 | $1,117,000.00 | |
| 2/28/2014 | Leon Hendrix, Jr. | Director | Sell | 23,000 | $20.09 | $462,070.00 | |
| 2/20/2014 | Aldo Magnini | Director | Sell | 6,000 | $22.10 | $132,600.00 | |
| 12/5/2013 | Paolo Russolo | Insider | Sell | 35,000 | $18.40 | $644,000.00 | |
| 11/11/2013 | Gregory Sargen | CFO | Sell | 20,000 | $18.92 | $378,400.00 | |
| 11/11/2013 | John Miller | Director | Sell | 2,000 | $19.21 | $38,420.00 | |
| 5/24/2013 | Paolo Russolo | Insider | Sell | 32,903 | $12.53 | $412,274.59 | |
| 5/16/2013 | Leon J Hendrix Jr | Director | Sell | 1,120 | $13.40 | $15,008.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Cambrex Corporation (NYSE:CBM)
Latest Headlines for Cambrex Corporation (NYSE:CBM)
| Source: |
|
| Date | Headline |
|---|
 | Cambrex Corporation (CBM) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 24 at 8:08 AM |
| Cambrex Corporation (CBM) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 7 at 11:16 AM |
 | Cleantech Building Materials: Grant of share options
finance.yahoo.com - July 7 at 5:39 AM |
| Steven M. Klosk Sells 12,000 Shares of Cambrex Corporation (CBM) Stock
www.americanbankingnews.com - July 5 at 7:06 PM |
| ETFs with exposure to Cambrex Corp. : July 4, 2017
finance.yahoo.com - July 4 at 9:48 PM |
| Cambrex Corporation (NYSE:CBM) Downgraded by Zacks Investment Research
www.americanbankingnews.com - July 4 at 7:44 PM |
| Zacks.com featured highlights: Hitachi, Koninklijke DSM, Embotelladora Andina, Cambrex and Ituran Location and Control
finance.yahoo.com - July 3 at 5:00 PM |
| Cleantech Building Materials: AGM Report
finance.yahoo.com - June 30 at 5:05 PM |
| The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics
finance.yahoo.com - June 22 at 11:23 AM |
| Cambrex Corporation (CBM) VP Samantha Hanley Sells 14,000 Shares
www.americanbankingnews.com - June 12 at 7:15 PM |
| Enzo Biochem (ENZ) Looks Good: Stock Jumps 13.3% in Session
finance.yahoo.com - June 12 at 5:12 PM |
| Cambrex Corporation (CBM) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 12 at 11:24 AM |
| Cambrex Corporation (CBM) Cut to "Hold" at ValuEngine
www.americanbankingnews.com - June 11 at 8:58 PM |
| Cambrex Co. (CBM) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - June 10 at 10:32 PM |
| Insider Selling: Cambrex Co. (CBM) Director Sells 20,656 Shares of Stock
www.americanbankingnews.com - June 8 at 7:12 PM |
| ETFs with exposure to Cambrex Corp. : June 8, 2017
finance.yahoo.com - June 8 at 5:10 PM |
| Cleantech Building Materials: Notice of AGM
finance.yahoo.com - June 7 at 4:28 PM |
| Cambrex Corp. :CBM-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
finance.yahoo.com - June 6 at 3:30 PM |
| Cambrex Co. (CBM) CEO Sells $650,280.00 in Stock
www.americanbankingnews.com - June 2 at 7:50 PM |
| Cambrex Corp. breached its 50 day moving average in a Bullish Manner : CBM-US : June 2, 2017
finance.yahoo.com - June 2 at 5:39 PM |
| Cleantech Building Materials: Ordinary Share Capital
finance.yahoo.com - May 31 at 4:14 PM |
| Cambrex to Present at the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 31 at 4:14 PM |
| ETFs with exposure to Cambrex Corp. : May 22, 2017
finance.yahoo.com - May 22 at 4:04 PM |
| Cleantech Building Materials: AMENDMENT OF LOAN FACILITY, DEBT CONVERSION AND ISSUE OF NEW SHARES
finance.yahoo.com - May 19 at 8:52 AM |
| Cleantech Building Materials: Reduction in Share Capital
finance.yahoo.com - May 17 at 11:44 AM |
| Cambrex to Present at the 2017 UBS Global Healthcare Conference
finance.yahoo.com - May 15 at 3:53 PM |
| Cambrex Corp. – Value Analysis (NYSE:CBM) : May 11, 2017
finance.yahoo.com - May 11 at 9:47 PM |
| Cambrex Co. (CBM) Upgraded at Zacks Investment Research
www.americanbankingnews.com - May 11 at 6:34 PM |
| Cambrex Corp. breached its 50 day moving average in a Bearish Manner : CBM-US : May 9, 2017
finance.yahoo.com - May 9 at 4:10 PM |
| Cambrex Co. (CBM) to Post Q2 2017 Earnings of $0.74 Per Share, First Analysis Forecasts
www.americanbankingnews.com - May 9 at 7:26 AM |
| Zacks: Brokerages Expect Cambrex Co. (CBM) Will Post Earnings of $0.78 Per Share
www.americanbankingnews.com - May 5 at 6:10 PM |
| Cambrex Co. (CBM) Posts Quarterly Earnings Results, Beats Expectations By $0.20 EPS
www.americanbankingnews.com - May 4 at 10:44 PM |
| Edited Transcript of CBM earnings conference call or presentation 4-May-17 12:30pm GMT
finance.yahoo.com - May 4 at 9:20 PM |
| Cambrex Reports First Quarter 2017 Financial Results
finance.yahoo.com - May 4 at 4:19 PM |
| Cambrex Co. (CBM) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 4 at 11:17 AM |
 | Cambrex posts 1Q profit
marketbeat.com - May 4 at 7:31 AM |
| Cambrex (CBM) Earns Daily News Sentiment Score of 0.37
www.americanbankingnews.com - May 3 at 12:54 AM |
| Insider Selling: Cambrex Co. (CBM) CEO Sells 12,000 Shares of Stock
www.americanbankingnews.com - May 2 at 9:26 PM |
| Cambrex Co. (CBM) Set to Announce Earnings on Thursday
www.americanbankingnews.com - May 2 at 1:21 PM |
| Cambrex to Announce First Quarter 2017 Financial Results on May 4, 2017
finance.yahoo.com - May 1 at 4:10 PM |
| Positive Media Coverage Likely to Impact Cambrex (CBM) Stock Price
www.americanbankingnews.com - April 27 at 2:28 PM |
| Cleantech Building Materials: General Meeting
finance.yahoo.com - April 26 at 3:08 PM |
| Somewhat Favorable News Coverage Very Likely to Affect Cambrex (CBM) Share Price
www.americanbankingnews.com - April 24 at 8:08 PM |
| Cleantech Building Materials: Settlement through VP Securities A/S
finance.yahoo.com - April 21 at 4:17 PM |
| Cleantech Building Materials: Issue of Shares
finance.yahoo.com - April 19 at 1:01 PM |
| Positive Media Coverage Very Unlikely to Effect Cambrex (CBM) Share Price
www.americanbankingnews.com - April 13 at 5:51 PM |
| Posting of Circular to Shareholders
finance.yahoo.com - April 7 at 4:10 PM |
| Steven M. Klosk Sells 12,000 Shares of Cambrex Co. (CBM) Stock
www.americanbankingnews.com - April 3 at 7:58 PM |
| Cleantech Building Materials: Annual Results to 31 December 2016
finance.yahoo.com - March 29 at 4:34 PM |
| Does Cambrex Offer a Great Value Buying Opportunity Right Now?
finance.yahoo.com - March 17 at 4:45 PM |
Cambrex Corporation (CBM) Chart for Wednesday, July, 26, 2017
